» Articles » PMID: 9558047

Analysis of Human T-cell Antigen Receptor Variable Beta Gene Usage Following Vaccination with Recombinant HBsAg

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1998 Apr 29
PMID 9558047
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the TcR Vbeta gene usage before and after vaccination with the hepatitis B vaccine since changes in the TcR Vbeta gene families would be considered to provide preliminary evidence of a mechanism to prevent HBV infection. Six healthy adult volunteers received immunizations. TcR Vbeta usage, T-cell proliferation, and HLA class II alleles were examined in peripheral blood mononuclear cells (PBMC) both before and after vaccination. Furthermore, TcR Vbeta usage in postimmunization PBMC was also compared with PBMC cultured with recombinant HBsAg (rHBsAg). The level of in vitro T-cell proliferation in the presence of rHBsAg increased significantly (P < 0.01) in PBMC isolated after vaccinations. Increases in the different TcR Vbeta genes were also observed in each individual following vaccinations, regardless of the similarity in their HLA alleles. Specific HBV-related antigen-responsive T cells were induced after HB vaccination, without any common restriction for the TcR Vbeta gene families. The mechanism that helps prevent HBV infection was thus found to involve multiclonal alterations in the TcR Vbeta repertoire.

Citing Articles

Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection.

Yang J, Chen J, He J, Xie Y, Zhu Y, Cao H Cell Mol Immunol. 2014; 11(4):332-42.

PMID: 25126662 PMC: 4085520. DOI: 10.1038/cmi.2014.22.


Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.

Hohn H, Neukirch C, Freitag K, Necker A, Hitzler W, Seliger B Clin Exp Immunol. 2002; 129(2):309-17.

PMID: 12165088 PMC: 1906443. DOI: 10.1046/j.1365-2249.2002.01841.x.

References
1.
Kaneshige T, Hashimoto M, Matsumoto Y, Kinoshita T, Hirasawa T, Uchida K . Serologic and nucleotide sequencing analyses of a novel DR52-associated DRB1 allele with the DR 'NJ25' specificity, designated DRB1*1307. Hum Immunol. 1994; 41(2):151-9. DOI: 10.1016/0198-8859(94)90009-4. View

2.
Margolis H . Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond. J Infect Dis. 1993; 168(1):9-14. DOI: 10.1093/infdis/168.1.9. View

3.
DUDLEY F, Fox R, Sherlock S . Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972; 1(7753):723-6. DOI: 10.1016/s0140-6736(72)90234-6. View

4.
Milich D . Immune response to hepatitis B virus proteins: relevance of the murine model. Semin Liver Dis. 1991; 11(2):93-112. DOI: 10.1055/s-2008-1040428. View

5.
Fink P, Matis L, McElligott D, Bookman M, Hedrick S . Correlations between T-cell specificity and the structure of the antigen receptor. Nature. 1986; 321(6067):219-26. DOI: 10.1038/321219a0. View